NCT00796211 - A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions

Plaque Psoriasis

Interventions

DRUG

CRx-197

CRx-197 high dose topical cream (0.1% nortriptyline HCl +0.3% loratadine)

DRUG

CRx-197

CRx-197 low dose topical cream (0.1% nortriptyline HCl + 0.1% loratadine)

DRUG

Nortriptyline

0.1% nortriptyline HCl topical cream

DRUG

Calcipotriol

0.005% calcipotriol topical cream

OTHER

Placebo

Vehicle of CRx-197 topical cream (placebo)

Trial Locations (1)

ProInnovera, Münster